Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxia

Published on: 20 July, 2020

Craig SG, Humphries MP, Alderdice M, Bingham V, Richman SD, Loughrey MB, et al. Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxia. Br J Cancer. 2020 Oct;123(8):1280-1288. Epub 2020 Jul 20.

Related Team Members

Dr Susan Richman

Multidisciplinary Pathology Deputy Lead

Professor Philip Quirke

Multidisciplinary Pathology Theme Lead

Share

Facebook
Twitter
LinkedIn